当前位置:首页 - 行情中心 - 神州细胞(688520) - 财务分析 - 现金流量表

神州细胞

(688520)

  

流通市值:154.58亿  总市值:163.25亿
流通股本:4.45亿   总股本:4.70亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金756,194,309.2376,514,303.961,725,605,641.841,309,082,892.53
  收到的税费返还103,057.0788,544.5749,182,974.0749,005,230.2
  收到其他与经营活动有关的现金10,277,374.442,442,053.12131,586,636.019,059,239.36
  经营活动现金流入小计766,574,740.71379,044,901.651,906,375,251.921,367,147,362.09
  购买商品、接受劳务支付的现金242,887,830.4100,892,701.06477,314,224.73337,514,864.37
  支付给职工以及为职工支付的现金360,550,005.46156,689,568.42715,282,895.84552,898,080.14
  支付的各项税费20,416,909.478,737,043.1473,002,599.3253,837,763.23
  支付其他与经营活动有关的现金354,748,175.23205,612,253.65916,377,288.41729,717,090.43
  经营活动现金流出小计978,602,920.56471,931,566.272,181,977,008.31,673,967,798.17
  经营活动产生的现金流量净额-212,028,179.85-92,886,664.62-275,601,756.38-306,820,436.08
二、投资活动产生的现金流量:
  收回投资收到的现金1,424,000,000650,000,0001,690,000,0001,130,000,000
  取得投资收益收到的现金1,733,107.23780,049.482,508,219.151,748,227.62
  投资活动现金流入小计1,425,733,107.23650,780,049.481,692,508,219.151,131,748,227.62
  购建固定资产、无形资产和其他长期资产支付的现金99,534,002.8486,733,460.81216,517,898.77166,106,189.33
  投资支付的现金1,600,000,000700,000,0001,767,970,510.731,313,970,510.73
  投资活动现金流出小计1,699,534,002.84786,733,460.811,984,488,409.51,480,076,700.06
  投资活动产生的现金流量净额-273,800,895.61-135,953,411.33-291,980,190.35-348,328,472.44
三、筹资活动产生的现金流量:
  吸收投资收到的现金896,000,000896,000,000565,000,00065,000,000
  取得借款收到的现金660,445,236.53214,437,829.422,386,519,7401,771,155,437.14
  筹资活动现金流入小计1,556,445,236.531,110,437,829.422,951,519,7401,836,155,437.14
  偿还债务支付的现金991,623,473.6206,461,173.181,789,474,962.191,000,107,292.86
  分配股利、利润或偿付利息支付的现金49,178,323.2620,296,291.51111,830,872.179,195,181.56
  支付其他与筹资活动有关的现金30,398,710.13540,931.9827,176,331.7220,080,233.87
  筹资活动现金流出小计1,071,200,506.99227,298,396.671,928,482,166.011,099,382,708.29
  筹资活动产生的现金流量净额485,244,729.54883,139,432.751,023,037,573.99736,772,728.85
四、汇率变动对现金及现金等价物的影响-53,129.893,134.43-58,686.45-59,520.03
五、现金及现金等价物净增加额-637,475.81654,302,491.23455,396,940.8181,564,300.3
  加:期初现金及现金等价物余额770,330,864.6770,330,864.6314,933,923.79314,933,923.79
  期末现金及现金等价物余额769,693,388.791,424,633,355.83770,330,864.6396,498,224.09
补充资料:
  净利润-377,200,763.09--566,202,185.71-
  资产减值准备12,406,663.68-19,642,764.22-
  固定资产和投资性房地产折旧65,104,858.91-132,843,564.09-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧65,104,858.91-132,843,564.09-
  无形资产摊销13,302,379.88-22,009,794.88-
  长期待摊费用摊销7,833,787.6-14,608,190.25-
  处置固定资产、无形资产和其他长期资产的损失---5,814.16-
  固定资产报废损失998.59--56,044.65-
  公允价值变动损失6,667,126.34--10,323,313.36-
  财务费用42,681,060.92-88,997,866.54-
  投资损失-1,262,830.55--1,253,907.51-
  递延所得税-1,734,126.76-2,580,828.34-
    递延所得税负债增加-1,734,126.76-2,580,828.34-
  存货的减少-31,749,261.09--83,384,704.4-
  经营性应收项目的减少49,092,036.55-174,258,043.8-
  经营性应付项目的增加-7,046,093.05--34,936,186.73-
  其他713,587.29--63,955,983.04-
  现金的期末余额769,693,388.79-770,330,864.6-
  减:现金的期初余额770,330,864.6-314,933,923.79-
  现金及现金等价物的净增加额-637,475.81-455,396,940.81-
公告日期2026-08-292026-04-302026-04-232025-10-31
审计意见(境内)标准无保留意见
TOP↑